News
Peptide nucleic acids (PNAs) are synthetic analogues of natural nucleic acids, distinguished by a peptide‐like backbone that confers unique binding affinities and high stability against ...
Recently, a team of researchers led by Ayhan Yurtsever, Takeshi Fukuma, and Linhao Sun from Kanazawa University, in collaboration with Yuhei Hayamizu at the Institute of Science Tokyo and Mehmet ...
Peptide nucleic acids (PNAs) represent a revolutionary class of synthetic nucleic acid analogues, in which the traditional sugar–phosphate backbone is replaced by a neutral N-(2-aminoethyl ...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-powered drug discovery and biotherapeutics, today announced ...
Frost & Sullivan released the "2025 China Pharmaceutical CDMO Industry Insight Blue Book", a comprehensive analysis of the ...
The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
Jiuzhou Pharma Achieves BSI Certification, Supporting Green, Low-Carbon, And Sustainable Development
A Jiuzhou Pharma employee loads samples into equipment. Zhejiang Jiuzhou Pharmaceutical Receives ISO 14064-1 Greenhouse Gas Emissio ...
2d
TipRanks on MSNAnalysts Predict Up to ~590% Spike for These 2 ‘Strong Buy’ Penny StocksWhile Wall Street focuses on the trillion-dollar club – think the ‘Magnificent 7’ – some of the most compelling opportunities ...
Given how severe the consequences could be, the creation of mirror bacteria by extreme malicious actors is a real concern that needs to be addressed in advance.
Northwestern University's International Institute for Nanotechnology (IIN) has announced the recipients of the 2025 ...
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results